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Raman spectroscopy (RS) is sensitive to the molecular composition of biological tissues. Raman optical fiber- 
based probes have demonstrated efficacy in noninvasive cancer screening of the skin, breast, stomach, cervical, 
lung and brain. Currently, statistical algorithms such as principle component analysis (PCA) are the standard 
approaches for describing the spectral variance of the RS data and providing tissue classification. However, a 
PCA-based analysis does not allow for an examination of the biophysical basis of disease, such as 
microstructural organization of proteins and lipids. Understanding those biophysical parameters is essential to 
interpret the diagnostic result similar to that a pathologist is familiar reading, and develop diagnostic algorithms 
for fast and accurate cancer screening. 
Here, we proposed the first biophysical Raman model for in vivo human skin cancer screening. The basic 
principle is to describe the in vivo human skin spectra as a linear combination of the basis spectra of the most 
relevant skin constituents. The fit parameters of the skin constituents provided insights into the biochemical and 
structural makeup of the skin tissue and were then used to develop diagnostic models to discriminate skin 
cancers. We expanded upon a previous skin cancer model [1] by using in situ skin constituents as the building 
blocks instead of synthetic chemicals to better represent the skin microenvironment. To achieve this goal, we 
performed Raman imaging on human skin sections using a custom built 830nm confocal Raman microscope 
(Figure 1) and collected a library of basis spectra for individual skin constituents. We then validated our model 
using a previous clinical screening study [2] that covered a wide range of nonmelanoma and melanoma skin 
disease states. Our model revealed the most relevant building blocks to represent the human skin RS data: 
collagen, elastin, keratin, triolein, ceramide, cell nucleus, melanin and water. More importantly, we found 
collagen and triolein were the most significant biomarkers in discriminating malignant melanoma from benign 
pigmented lesions, and discriminating nonmelanoma skin cancer from normal skin. In the long term, our 
biophysical Raman model has the potential to impact the screening and margin assessment in other cancer 
types, such as breast, colorectal and prostate. 
 
 
Figure 1 Raman imaging of a human basal cell carcinoma (BCC) skin section. Concentration images of 3 
components were reconstructed by multivariate curve resolution (MCR) analysis. The corresponding Raman 
spectra are shown on the right. 
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